NYSE:MMM - 3M Stock Price, Forecast & News

3M's stock was trading at $147.24 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, MMM stock has decreased by 7.3% and is now trading at $136.51. View which stocks have been mosted impacted by Coronavirus.

12 Wall Street analysts have issued "buy," "hold," and "sell" ratings for 3M in the last year. There are currently 3 sell ratings, 8 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for 3M.

3M is scheduled to release its next quarterly earnings announcement on Thursday, April 23rd 2020. View our earnings forecast for 3M.

3M Co (NYSE:MMM) issued its quarterly earnings results on Tuesday, January, 28th. The conglomerate reported $1.95 earnings per share for the quarter, missing the Zacks' consensus estimate of $2.10 by $0.15. The conglomerate had revenue of $8.11 billion for the quarter, compared to analysts' expectations of $8.12 billion. 3M had a net margin of 14.22% and a return on equity of 51.39%. The firm's revenue for the quarter was up 2.1% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $2.31 earnings per share. View 3M's earnings history.

3M declared a quarterly dividend on Tuesday, February 4th. Stockholders of record on Friday, February 14th will be paid a dividend of $1.47 per share on Thursday, March 12th. This represents a $5.88 dividend on an annualized basis and a dividend yield of 4.31%. The ex-dividend date of this dividend is Thursday, February 13th. This is a positive change from 3M's previous quarterly dividend of $1.44. View 3M's dividend history.

3M declared that its board has authorized a share buyback plan on Tuesday, November 13th 2018, which permits the company to buyback $10,000,000,000.00 in outstanding shares, according to EventVestor. This buyback authorization permits the company to repurchase up to 8.7% of its stock through open market purchases. Stock buyback plans are generally a sign that the company's management believes its shares are undervalued.

3M issued an update on its FY20 earnings guidance on Tuesday, January, 28th. The company provided EPS guidance of $9.30 to $9.75 for the period, compared to the Thomson Reuters consensus EPS estimate of $9.61. The company issued revenue guidance of $32 billion to $32.74 billion, compared to the consensus revenue estimate of $33.70 billion.

12 analysts have issued 12-month price targets for 3M's stock. Their forecasts range from $150.00 to $194.00. On average, they expect 3M's stock price to reach $170.67 in the next year. This suggests a possible upside of 25.0% from the stock's current price. View analysts' price targets for 3M.

News articles about MMM stock have been trending very negative recently, according to InfoTrie Sentiment Analysis. The research group ranks the sentiment of news coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. 3M earned a media sentiment score of -3.0 on InfoTrie's scale. They also assigned media headlines about the conglomerate a news buzz of 4.0 out of 10, indicating that recent news coverage is somewhat unlikely to have an effect on the stock's share price in the next several days. View the latest news about3M.

3M saw a decrease in short interest during the month of March. As of March 13th, there was short interest totaling 8,155,200 shares, a decrease of 11.6% from the February 27th total of 9,230,000 shares. Based on an average trading volume of 3,720,000 shares, the short-interest ratio is presently 2.2 days. Approximately 1.4% of the shares of the stock are sold short. View 3M's Current Options Chain.

Some companies that are related to 3M include Stryker (SYK), Becton Dickinson and (BDX), Boston Scientific (BSX), Baxter International (BAX), DexCom (DXCM), FRESENIUS SE &/S (FSNUY), ResMed (RMD), Teleflex (TFX), Insulet (PODD), Hill-Rom (HRC), ABIOMED (ABMD), Novocure (NVCR), Penumbra (PEN), Haemonetics (HAE) and Globus Medical (GMED).

Based on aggregate information from My MarketBeat watchlists, some companies that other 3M investors own include Johnson & Johnson (JNJ), AT&T (T), Walt Disney (DIS), Cisco Systems (CSCO), Exxon Mobil (XOM), Intel (INTC), Verizon Communications (VZ), Home Depot (HD), Procter & Gamble (PG) and Mcdonald's (MCD).

3M trades on the New York Stock Exchange (NYSE) under the ticker symbol "MMM."

Shares of MMM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of MMM stock can currently be purchased for approximately $136.51.

3M has a market capitalization of $78.50 billion and generates $32.14 billion in revenue each year. The conglomerate earns $4.57 billion in net income (profit) each year or $9.10 on an earnings per share basis. 3M employs 96,163 workers across the globe. View additional information about 3M.

The official website for 3M is http://www.3m.com/.

3M's mailing address is 3M CENTER BLDG. 220-11W-02, ST PAUL MN, 55144. The conglomerate can be reached via phone at 651-733-1110.